Perflow Medical

Company Overview

Snapshot

Founded in March 2010 by Danny Farin, Eyal Orion, Avi Rappaport, and Gilad Cibulski, Perflow Medical operates with 11–50 employees. The company has secured $13.6M in total capital across two funding rounds from five investors. In January 2022, a Chinese fund acquired Perflow Medical for $100 million.

Business overview

Perflow Medical develops, manufactures, and commercializes neurovascular interventional products aimed at improving patient clinical outcomes. The company's CEREBRAL NET technological platform underpins three neurovascular treatment devices for thrombectomy, aneurysm neck bridging, and flow diversion. Perflow's technology also facilitates the creation of new device categories for novel endovascular treatment approaches across various indications. The company's Stream Dynamic Neuro-Thrombectomy Net and Cascade Non-Occlusive Remodeling Net are CE marked, serving the medical devices sector within the Health Tech & Life Sciences industry.

Strategic signal

The acquisition of Perflow Medical by a Chinese fund for $100 million in January 2022 signals strong market validation for its neurovascular technology. This exit demonstrates the significant commercial potential and strategic value of Perflow's innovative devices, particularly in the global medical device market, and suggests a positive trajectory for its continued development and market penetration under new ownership.

Company Intelligence Q&A

When was Perflow Medical acquired and for what amount?

Perflow Medical was acquired by a Chinese fund for $100 million in January 2022.

What was the company's last disclosed financing round?

In February 2018, Perflow Medical closed a financing round with participation from.

When did Perflow Medical announce the first clinical use of its Cascade™ 17 Dynamic Non-Occlusive Remodeling Net?

Perflow Medical announced the first clinical use of its Cascade™ 17 Dynamic Non-Occlusive Remodeling Net in March 2021.

Which of Perflow Medical's products received CE Mark approval in October 2019?

In October 2019, Perflow Medical received CE Mark approval for its novel Cascade™ Agile.

When did Perflow Medical expand its product portfolio with the first clinical use of the Stream™17 Dynamic Neuro-Thrombectomy Net?

Perflow Medical expanded its product portfolio with the first clinical use of the Stream™17 Dynamic Neuro-Thrombectomy Net in April 2021.